PIA
IONS icon

Piedmont Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Piedmont Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,233
Closed -$531K – 340
2020
Q1 		$531K Buy
11,233
+1,675
+18% +$93.4K 0.02% 432
2019
Q4 		$577K Sell
9,558
-40
-0.4% -$2.38K 0.02% 466
2019
Q3 		$575K Buy
9,598
+162
+2% +$10.6K 0.02% 464
2019
Q2 		$606K Buy
9,436
+382
+4% +$27K 0.02% 464
2019
Q1 		$735K Sell
9,054
-17
-0.2% -$1.1K 0.03% 376
2018
Q4 		$490K Buy
9,071
+35
+0.4% +$1.78K 0.02% 467
2018
Q3 		$466K Buy
+9,036
New +$425K 0.02% 552

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Piedmont Investment Advisors's IONS Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2020, closing a stake of 11,233 shares — an estimated $531K sold.

Piedmont Investment Advisors first reported a position in IONS in Q3 2018 and held it in 7 quarters. The position peaked at $735K in Q1 2019. 376 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 11,233 Ionis Pharmaceuticals shares in Q2 2020, an estimated $531K.
  • Piedmont Investment Advisors first reported a position in Ionis Pharmaceuticals in Q3 2018 and held it in 7 quarters.
  • Piedmont Investment Advisors's Ionis Pharmaceuticals position peaked at $735K in Q1 2019.
  • 376 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.